Fmoc-Lys(tBuO-Ara-Glu(AEEA-AEEA)-OtBu)-OH is a key drug intermediate in the synthesis of Tirzepatide, which functions as a dual agonist of the glucose-dependent insulinotropic peptide (GIP) and the glucagon-like peptide-1 receptor (GLP-1R). This compound is essential for research and development in diabetes therapeutics, as Tirzepatide enhances insulin secretion and improves glycemic control. Its structural features facilitate the exploration of peptide-based treatments for metabolic disorders.
Fmoc-Lys(tBuO-Ara-Glu(AEEA-AEEA)-OtBu)-OH is a key drug intermediate in the synthesis of Tirzepatide, which functions as a dual agonist of the glucose-dependent insulinotropic peptide (GIP) and the glucagon-like peptide-1 receptor (GLP-1R). This compound is essential for research and development in diabetes therapeutics, as Tirzepatide enhances insulin secretion and improves glycemic control. Its structural features facilitate the exploration of peptide-based treatments for metabolic disorders.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
